Histologically, CC can be characterized by two different sub-categories i.e. (i) invasive squamous cell carcinomas (ISCC) which are frequent and covers 85–90% of CC cases (ii) adenocarcinomas (ADC) which are relatively rare and comprises only 10–15% cases. The CC develops progression of precancerous lesions; called cervical intraepithelial neoplasia (CIN) grade 1–3 or squamous intraepithelial lesion (SIL).
This is the third national call to action from NCI-designated cancer centers, with the first statement published in 2016. All 70 cancer centers, representing the nation’s leaders in cancer care and research, perceive low vaccination rates as a public health threat and call upon physicians, parents and young adults to take advantage of this opportunity…
Every year, 21,000 women in the UK develop a gynaecological cancer. Yet it seems we’re still a nation too shy to speak up, with a fifth of women feeling unable to speak to their GP about their symptoms. This is why women’s charity The Eve Appeal and the beauty industry’s Cosmetic Executive Women (CEW) have…
Regeneron and Sanofi Share First Positive Clinical Data for Cemiplimab in Cervical Cancer at ASCO- New Drug on the Block Soon!
Source: https://www.onclive.com/onclive-tv/dr-ginsburg-discusses-global-vaccination-and-screening-for-cervical-cancer
FOR most women, smear or Pap tests are an uncomfortable but necessary chore. More properly known as cervical cancer screening tests, they usually involve lying down with your legs apart while a doctor or nurse swabs some cells from the top of your vagina. No one likes it, but it is not usually painful and…